Eurogentec
Eurogentec is a Belgian GMP-accredited, FDA-inspected CDMO and life science reagents manufacturer producing catalog and custom oligonucleotides, mRNA, peptides, antibodies, and recombinant proteins for pharmaceutical, diagnostic, and academic customers globally as a subsidiary of Kaneka Corporation.
- Company typePrivate
- Founded1985
- HeadquartersSeraing-le-château, Belgium
- Headcount251–500
- GTM typeB2B
- OfferingHardware or Manufacturing
What Eurogentec does
Eurogentec (legal entity Kaneka Eurogentec S.A.) is a Belgian life science manufacturing company headquartered in Seraing, Belgium, founded in 1985 and operating as a wholly-owned subsidiary of Japan's Kaneka Corporation since 2006. The company runs GMP-accredited and FDA-inspected production facilities exceeding 10,000 m², supplying catalog and custom nucleic acid reagents, peptides, antibodies, recombinant proteins, qPCR kits, and CDMO services spanning therapeutic oligonucleotides, GMP IVT-mRNA (up to 50g per batch, equivalent to 100,000s to millions of doses), plasmid DNA, and VHH antibody fragments at kilogram scale.
Its technology stack centers on proprietary oligonucleotide synthesis with extensive modification capability (ASO, siRNA, NGS oligos, aptamers), an in-house rapid VHH/nanobody manufacturing platform from camelid immunization through GMP production, large-scale IVT mRNA synthesis and purification, and a portfolio of IP-free ATTO dyes for qPCR and dPCR probe applications. The offering combines high-purity catalog products (over 1,000 catalog peptides, Takyon® qPCR kits, MapMarker® ladders) with quote-based custom synthesis and multi-year contract manufacturing for clinical and commercial human therapeutics.
Eurogentec generates revenue across five streams: catalog and custom oligonucleotide product sales, GMP CDMO services for pharma and biotech clients, custom antibody and VHH production, custom peptide synthesis, and reagents/assay kits. Pricing is unit-based for catalog research products and quote-based for custom synthesis and GMP manufacturing, with multi-year contracting common for CDMO and OEM kit engagements. Customers are segmented across pharmaceutical/biotech (primary), diagnostics (primary), and academic/research institutions, served globally from Belgium via direct field sales for BLA-grade contracts and e-commerce for research-grade consumables, supplemented by a regional distributor network.
Eurogentec firmographics
Firmographics- Name
- Eurogentec
- Legal name
- Kaneka Eurogentec S.A.
- Website
- https://eurogentec.com
- Company type
- Private
- Founded year
- 1985
- Operating status
- Operating
- Headcount range
- 251–500 employees
- Short description
- Eurogentec is a Belgian GMP-accredited, FDA-inspected CDMO and life science reagents manufacturer producing catalog and custom oligonucleotides, mRNA, peptides, antibodies, and recombinant proteins for pharmaceutical, diagnostic, and academic customers globally as a subsidiary of Kaneka Corporation.
- Ownership category
- akta.pro rank
Eurogentec industry classification
Industry- Product category
- Biopharmaceutical CDMO and Life Science Reagents
- NAICS
- Pharmaceutical Preparation Manufacturing (325412), Biological Product (except Diagnostic) Manufacturing (325414), Pharmaceutical and Medicine Manufacturing (3254), In-Vitro Diagnostic Substance Manufacturing (325413)
- SIC
- Pharmaceutical Preparations (2834), Biological Products, (No Disgnostic Substances) (2836), Medicinal Chemicals & Botanical Products (2833)
- akta.pro primary industry
- mRNA/LNP & Nucleic Acid Therapeutics CDMO (HLAGABAF)
- akta.pro secondary industries
- Clinical Trial Material (CTM) Manufacturing & Supply CDMO (HLAGABAK), Gene Therapy (Viral Vector/Plasmid) CDMO (HLAGABAE), Biologics (mAbs/Recombinant Proteins) CDMO (HLAGABAC), Gene Therapy Vector Manufacturing & CDMO Services (HLAAACAJ)
Keywords
Where Eurogentec is headquartered
LocationHeadquarters
- HQ city
- Seraing-le-château
- HQ country
- Belgium
- HQ region
- Europe
Offices1 record
Markets served
Eurogentec business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Operations, Infrastructure, Technology or R&D, Supply Chain, Marketing or Sales
Revenue model
- Oligonucleotide Products: Catalog and custom oligonucleotides including research oligos, diagnostic oligos, ASR oligos, and pre-clinical/therapeutic oligos. Revenue from product sales of various purity grades and modifications.
- GMP CDMO Services: Contract development and manufacturing services for pharmaceutical companies including GMP mRNA synthesis, plasmid DNA manufacturing, therapeutic peptides, and antibody fragment production for clinical trials and commercialization.
- Antibody Products and Services: Custom polyclonal and monoclonal antibody development, VHH development, and industrial-scale antibody production services.
- Peptide Products: Custom peptide synthesis and catalog peptides including modified peptides, fluorescent labeled peptides, and GMP peptides for research and clinical applications.
- Reagents and Assay Kits: qPCR kits, extraction/purification kits, electrophoresis systems, labeling reagents, and assay kits for research applications.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Catalog Research Products |
| Other | Multi-year contract | Custom Synthesis and GMP Manufacturing |
| Transaction based/ take rate | Multi-year contract | OEM Kit Manufacturing |
Go-to-market motion1 record
Distribution channels4 records
Marketing channels6 records
Eurogentec product offering
Product offeringCore offering
Eurogentec manufactures and sells life-science reagents (catalog and custom oligonucleotides, peptides, antibodies, recombinant proteins, qPCR kits) and provides GMP contract development and manufacturing organization (CDMO) services for mRNA, plasmid DNA, therapeutic oligonucleotides, and antibody fragments. Its products serve pharmaceutical, biotech and diagnostic customers from research through clinical and commercial stages of nucleic acid and protein therapeutics development.
Product overview
Eurogentec is a Belgian biotech company and contract development and manufacturing organization (CDMO) founded in 1985, operating under the Kaneka Group. The company offers a comprehensive portfolio of life science research reagents and GMP manufacturing services. The product portfolio centers on oligonucleotides (catalog and custom synthesis including RNA/DNA oligos, siRNA, ASO, probes, and specialized oligos), peptides (custom synthesis and 1,000+ catalog peptides), antibodies (custom polyclonal/monoclonal production and VHH/nanobody services), recombinant proteins, and qPCR/RT-qPCR reagent kits. The CDMO services division provides GMP manufacturing of therapeutic oligonucleotides, mRNA (up to 50g batch scale), peptides, and plasmid DNA/recombinant proteins for clinical and commercial applications. The company operates over 10,000 m² of production area and is GMP accredited with FDA inspection capability.
Differentiator
Problem solved
Functional benefit
Products and services
- Oligonucleotides (Oligos) Catalog and custom oligonucleotides including research oligos, diagnostic/testing oligos, ASR oligos, and pre-clinical/therapeutic oligos with various modifications, purifications, and scales, sold to researchers, diagnostics developers, and therapeutic developers.
- Custom Oligos Custom oligonucleotide manufacturing offering backbones, modifications, purifications, additional QC, custom format and packaging, and OEM kit manufacturing for diagnostics and research customers.
- Probes qPCR and dPCR probes including Double-Dye Probes, MGB Probes, Molecular Beacons, and IP-friendly Dyes and Quenchers, with design assistance, for diagnostics developers and molecular biology researchers.
- RNAi Products RNA interference products including custom siRNA duplexes, siRNA controls, and miRNA mimics and inhibitors, for gene silencing research and therapeutic development.
- Specialized Oligos Advanced oligonucleotide products including ASO oligos, oligos for screening, peptide-oligonucleotide conjugates, complex oligos, large scale oligos, oligo aptamers, and NGS oligos, for therapeutic developers and advanced research applications.
- GMP IVT-RNA Manufacturing GMP-grade in vitro transcription RNA manufacturing service for clinical and commercial applications, with capacity up to 50g per batch, serving pharmaceutical and biotech customers developing mRNA therapeutics and vaccines.
- GMP Therapeutic Oligonucleotides GMP synthesis of therapeutic oligonucleotides for pre-clinical and clinical use, serving pharmaceutical and biotech developers of nucleic acid therapeutics.
- GMP Peptide Manufacturing GMP-grade custom peptide synthesis for therapeutic and diagnostic applications, serving pharmaceutical and biotech customers advancing peptide-based drugs through clinical development.
- Takyon® qPCR Kits Quantitative PCR reagent kits for probe assays and SYBR® assays including Takyon® Etheris for microbial qPCR and MMx for complex samples and multiplexing, for diagnostics labs and research users.
- Quantitative Reverse Transcription PCR Kits One-step and two-step RT-qPCR kits for gene expression analysis, virus detection, and multiplexing applications, for diagnostics and research laboratories.
- Endpoint PCR Products PCR reagents including PCR mixes, DNA polymerases, reverse transcriptase, and dNTP mixes for endpoint PCR applications, for molecular biology research and diagnostic workflows.
- Antibody Production Services Custom polyclonal and monoclonal antibody production services, including hybridoma development, VHH development, and industrial-scale GMP antibody fragment manufacturing, for diagnostics developers and pharmaceutical researchers.
- GMP VHH Antibody Manufacturing GMP production of VHH (nanobody) antibody fragments, from camelid immunization through purification, serving pharmaceutical and biotech customers developing nanobody therapeutics and diagnostics.
- Custom Peptide Synthesis Custom peptide synthesis services including fluorescent-labeled peptides, FRET peptides, cyclic peptides, stapled peptides, phosphorylated peptides, and peptide libraries, for research and preclinical therapeutic development.
- Catalog Peptides Collection of over 1,000 catalog peptides across 12 research areas including neuroscience, cardiovascular, diabetes, cancer, immunology, epigenetics, and hormones, with ≥95% HPLC purity, for life science researchers.
- Assay Kits Ready-to-use assay kits for neuroscience, cardiovascular research, cancer research, cell biology, viral/bacterial proteases, diabetes, and ELISA applications, for academic and pharma research laboratories.
- Recombinant Proteins Catalog recombinant proteins for neuroscience, cardiovascular, adhesion, and epigenetics research, including GMP recombinant proteins for clinical use, serving research and pharmaceutical customers.
- Large Scale GMP BioManufacturing Plasmid DNA, recombinant proteins, and antibody fragment production up to kilogram scale for clinical and commercial human use, serving pharmaceutical and biotech customers requiring GMP biomanufacturing capacity.
- MapMarker® Fluorescent dye-labeled molecular weight ladder for electrophoresis applications, sold to molecular biology research and diagnostics labs.
- ATTO Dyes IP-free ATTO dyes for qPCR and dPCR probe applications with an extended selection, for diagnostics developers and researchers building probe panels.
Quantifiable outcome
- 50g mRNA per single batch - equivalent to 100,000s to millions of mRNA doses
Companies that use Eurogentec
Customer profileSegments3 records
Ideal customer profiles3 records
Eurogentec technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Eurogentec partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Kaneka GroupcoreEurogentec is a subsidiary of Kaneka Group, a Japanese chemical and pharmaceutical company. Kaneka Eurogentec operates as the Belgian entity within the larger Kaneka organization, providing life science and biotech solutions globally.
Scale indicators6 records
Recent moves6 records
Expansion highlights5 records
Eurogentec competitors and assessment
Company assessmentMarket position
Strengths4 records
Competitive moat5 records
Key risks5 records
Key highlights6 records
Customer concentration
Eurogentec social profiles
Digital presenceEurogentec financial estimates
Financial estimateRevenue estimate
Valuation estimate
Eurogentec leadership team
Management profileNumber of profiles
Profiles1 record
Eurogentec funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Eurogentec M&A and investment
M&A and investmentM&A1 record
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Eurogentec
What does Eurogentec do?
Eurogentec manufactures and sells life-science reagents (catalog and custom oligonucleotides, peptides, antibodies, recombinant proteins, qPCR kits) and provides GMP contract development and manufacturing organization (CDMO) services for mRNA, plasmid DNA, therapeutic oligonucleotides, and antibody fragments. Its products serve pharmaceutical, biotech and diagnostic customers from research through clinical and commercial stages of nucleic acid and protein therapeutics development.
Is Eurogentec a public or private company?
Eurogentec is a private company. It is classified as corporate owned and is currently operating.
When was Eurogentec founded?
Eurogentec was founded in 1985. It employs 251 to 500 people.
Where is Eurogentec based?
Eurogentec is headquartered in Seraing-le-château, Belgium, in the Europe region.
How does Eurogentec make money?
Five revenue lines are on record. Oligonucleotide Products are the primary driver. The others are GMP CDMO Services, antibody Products and Services, peptide Products and reagents and Assay Kits.
Does Eurogentec have an API?
No public API is recorded for Eurogentec.
What industry is Eurogentec in?
Eurogentec's product category is Biopharmaceutical CDMO and Life Science Reagents. Its primary akta.pro industry code is HLAGABAF, mRNA/LNP & Nucleic Acid Therapeutics CDMO, with a secondary code of HLAGABAK, Clinical Trial Material (CTM) Manufacturing & Supply CDMO. Its NAICS code is 325412 and its SIC code is 2834.